Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs

Use of toremifene and its metabolites for the reversal of multidrug resistance of cancer cells against cytotoxic drugs

US Patent 4990538 · Granted Feb 5, 1991

Assignee

No assignee recorded.

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Medicine for Covid-19 and treatment2023
Medicine for Covid-19 and treatment2022
Medicine for Covid-19 and treatment2021
Therapeutically active estratrienthiazole derivatives as inhibitors of 17 B-hydr2019
Methods for immunomodulation of cancer and infectious disease therapy2018
Therapeutically active estratrienthiazole derivatives as inhibitors of 17.beta-h2017
Therapeutically active 17-nitrogen substituted estratreinthiazole derivatives as2017
Method for the alleviation of dyspareunia in women2017
Method for the alleviation of dyspareunia in women2017
Methods of enhancing the response to radiation in tumor therapy using anti-DLL4 2014
MN gene and protein2012
MN/CA IX and breast cancer therapy2012